Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Neurexin 1 ELISA Kit (AC3596)
Cat.#: ASET-2185
Specifications
Description Human Neurexin 1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Neurexin 1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.91 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 150-2400 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1838 Human LST1 ELISA Kit (AC3249) Quantitative inquiry ASET-1176 Human CD97 ELISA Kit (AC2587) Quantitative inquiry ASET-1306 Human Gastrin Releasing Peptide ELISA Kit (AC2717) Quantitative inquiry ASET-1568 Human GPCR GPR35 ELISA Kit (AC2979) Quantitative inquiry ASET-2379 Human EN2 ELISA Kit (AC3790) Quantitative inquiry ASET-1637 Human PPAR gamma ELISA Kit (AC3048) Quantitative inquiry ASET-2066 Porcine LIF ELISA Kit (AC3477) Quantitative inquiry ASET-2362 Mouse GJB2 ELISA Kit (AC3773) Quantitative inquiry ASET-1616 Human 5HT2A Receptor ELISA Kit (AC3027) Quantitative inquiry ASET-1835 Human Hemojuvelin ELISA Kit (AC3246) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket